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Hematopoietic stem cells (HSCs) reside and self-
renew in the bone marrow (BM) niche. Overall, the
signaling that regulates stem cell dormancy in the
HSC niche remains controversial. Here, we demon-
strate that TGF-b type II receptor-deficient HSCs
show low-level Smad activation and impaired long-
term repopulating activity, underlining the critical
role of TGF-b/Smad signaling in HSC maintenance.
TGF-b is produced as a latent form by a variety of
cells, so we searched for those that express activator
molecules for latent TGF-b. Nonmyelinating
Schwann cells in BM proved responsible for activa-
tion. These glial cells ensheathed autonomic nerves,
expressed HSC niche factor genes, and were in
contact with a substantial proportion of HSCs. Auto-
nomic nerve denervation reduced the number of
these active TGF-b-producing cells and led to rapid
loss of HSCs from BM. We propose that glial cells
are components of a BM niche and maintain HSC
hibernation by regulating activation of latent TGF-b.
INTRODUCTION
Self-renewal, differentiation, and the cell cycle of hematopoietic
stem cells (HSCs) are thought to be regulated by the signals
provided by specific niches in bone marrow (BM). Many different
cell types have been characterized as contributors to the forma-
tion of HSC niches, such as osteoblasts (Zhang et al., 2003; Calvi
et al., 2003; Arai et al., 2004), endothelial cells (Kiel et al., 2005),
chemokine (C-X-C motif) ligand 12 (CXCL12)-abundant reticular
(CAR) cells (Sugiyama et al., 2006), and mesenchymal stem cells
(MSCs) (Me´ndez-Ferrer et al., 2010). These cells are believed to1146 Cell 147, 1146–1158, November 23, 2011 ª2011 Elsevier Inc.providemicroenvironments for HSC self-renewal, differentiation,
mobilization, and hibernation by cell-to-cell contact and soluble
factors, including angiopoietin-1 (Ang-1) (Arai et al., 2004), Ca2+
ions, CXCL12, sonic hedgehog, osteopontin, stem cell factor
(SCF), and thrombopoietin (TPO). Contributions by as yet
unidentified cells and factors have also been speculated (Kiel
and Morrison, 2008).
Most HSCs in the BM niche are in a hibernating state from
which they are occasionally aroused to undergo cell division
on average every 1–2 months (Sudo et al., 2000; Foudi et al.,
2009; Bradford et al., 1997; Cheshier et al., 1999). We recently
demonstrated that lipid raft clustering is a key event in the regu-
lation of HSC hibernation (Yamazaki et al., 2006). Lipid raft clus-
tering, as induced by cytokines, augmented signals that
appeared essential for HSC entry into the cell cycle. Conversely
ex vivo, inhibition of lipid raft clustering caused sustained nuclear
accumulation of FoxO transcription factors and induced HSC
hibernation. These findings established a critical role for lipid
rafts in regulating the cell cycle, survival, and apoptosis of
HSCs and uncovered a striking similarity between HSC hiberna-
tion and C. elegans dauer formation.
We hypothesized that a niche factor regulates the lipid raft
clustering of HSCs in vivo. Screening of candidate niche signals
revealed that transforming growth factor b (TGF-b) efficiently
inhibited cytokine-mediated lipid raft clustering and induced
HSC hibernation ex vivo, establishing TGF-b as a candidate
niche signal in the control of HSC dormancy (Yamazaki et al.,
2009). TGF-b negatively regulates HSC and hematopoietic
progenitor cell proliferation in vitro (Larsson and Karlsson,
2005). TGF-bs are secreted as part of the large latent complex
(LLC) consisting of TGF-b, latency-associated protein (LAP),
and latent TGF-b binding protein-1 (LTBP-1) (Annes et al.,
2003). Because LTBP-1, a member of the LTBP/fibrillin family,
covalently binds to extracellular matrix (ECM) proteins, the LLC
accumulates in the ECM (Annes et al., 2003). Under most condi-
tions TGF-b in the LLC is inactive and is thus called latent TGF-b.
Therefore, TGF-b function is largely controlled by activation of
latent TGF-b, a process that involves dissociation of bioactive
TGF-b from LAP. As such, we further hypothesized that cells
that activate latent TGF-b were a component of the BM HSC
niche and sought them in BM. Glial fibrillary acidic protein
(GFAP)-expressing cells (‘‘glial cells’’) were unexpectedly identi-
fied as the cells that principally process latent TGF-b into active
TGF-b in BM. These GFAP-positive cells were nonmyelinating
Schwann cells, which ensheath sympathetic nerves in BM.
They produced niche factors and were in direct contact with
a significant proportion of HSCs. Most strikingly, autonomic
nerve denervation of BM reduced the number of these TGF-b
secreting glial cells and led to the disappearance of CD34KSL
HSCs.
RESULTS
TGF-b/Smad Signaling Is Active in HSCs in BM
To ascertain how TGF-b controls hibernation of HSCs, we first
generated lymphocyte-deficient conditional TGF-b type II
receptor (TbRII)-deficient mice. TGF-b binds to its receptor
composed of TbRII and TGF-b type I receptor (TbRI) (Waite
and Eng, 2003; Schmierer and Hill, 2007). TGF-bs are multipo-
tent cytokines that modulate cell growth, inflammation, matrix
synthesis, and apoptosis (Waite and Eng, 2003; Schmierer and
Hill, 2007), and Tgfb1 null mice develop a lethal inflammatory
disorder (LID) affecting multiple organs that is caused by uncon-
trollable overreaction of lymphocytes. Similarly, immune cells
from Tgfbr2 knockout mice should induce LID upon transplanta-
tion. Therefore, we generated Mx-1-Cre:Tgfbr2flox/:Rag2/
mice by crossing Tgfbr2+/ mice (Oshima et al., 1996),
Tgfbr2flox/+ mice (Leve´en et al., 2005), Rag2/ mice, and inter-
feron-inducible Mx-1-Cre transgenic mice. To induce Cre, poly-
inosinic-polycytidylic acid (pIpC) was injected intraperitoneally
three times every other day. Mx-1-Cre:Tgfbr2flox/:Rag2/
mice lacking T and B lymphocytes did not develop LID. Two
weeks after pIpC injection, total BM cells from Mx-1-
Cre:Tgfbr2+/:Rag2/ mice or Mx-1-Cre:Tgfbr2flox/:Rag2/
mice (B6-Ly5.1) were infused into lethally irradiated recipients
(B6-Ly5.2) along with the same number of BM competitor cells
from B6-Ly5.1xLy5.2 F1 mice. The repopulation capacity of
test cells wasmonitored in terms of peripheral blood (PB) chime-
rism (Figure 1A). Because Rag2/ cells do not give rise to B and
T cells, only myeloid cells were gated upon analysis. The contri-
bution of Tgfbr2del/Rag2/ BM cells to PB myeloid cells grad-
ually declined over time (Figure 1B).
After binding to its ligand, the activated TGF-b receptor
complex subsequently phosphorylates receptor-activated
Smads (R-Smads) 2 and 3. R-Smads eventually heterodimerize
with the common mediator Smad4. The resulting ternary
complex translocates to the nucleus, where it recruits transcrip-
tional cofactors to control expression of genes, including those
involved in the cell cycle (Larsson and Karlsson, 2005; Waite
and Eng, 2003; Schmierer and Hill, 2007). Immunostaining
in wild-type BM sections revealed that a high proportion of
BM cells expressed phosphorylated Smad2/3 (Figure 1C).
Smad2/3 have been shown to be activated broadly among
different developmental stages of hematopoietic cells. AmongCmembers of the TGF-b family, Nodal and Activin are known to
phosphorylate Smad2/3 (Larsson and Karlsson, 2005). Although
T cells can respond to both Activin and TGF-b (Rosendahl et al.,
2003), we have shown that HSCs do not respond to Activin or
Nodal (Yamazaki et al., 2009). To evaluate pSmad2/3 status
within HSCs, BM sections were stained with anti-CD150,
-CD48, -CD41, and -lineage marker antibodies (Kiel et al.,
2005) and analyzed using ArrayScan technology (see Figure S1
available online). ArrayScan can quantitatively analyze BM histo-
logical sections containing large numbers of cells (Figure S1A)
and can backtrack the location and phosphorylation status of
individual very rare CD150+CD48CD41Lin HSCs (Figure 1D;
Figure S1B; scattergram gated in a red square, and Figures S1C
and S1D). We confirmed that these HSCs were phosphorylated
with Smad2/3 in a fashion similar to that in freshly isolated
wild-type CD34KSL HSCs as previously observed (Figure 1D)
(Yamazaki et al., 2009).
We then examined the phosphorylation status of Smad2 and
Smad3 in Tgfbr2del/Rag2/ CD34KSL HSCs 2 weeks after
pIpC injection. As expected, the levels of pSmad2/3 were signif-
icantly lower than those in Tgfbr2+/+Rag2/ CD34KSL HSCs
(Figure 1E). In parallel with the reduction in p-Smad2/3 expres-
sion, a significantly higher proportion of Tgfbr2del/Rag2/
CD34KSL HSCs entered the cell cycle within 1 week compared
with Tgfbr2+/Rag2/ HSCs, as determined by a bromodeox-
yuridine (BrdU) incorporation assay (Figure 1F). Loss of Tgfbr2
was associated with reduced p-Smad2/3, increased cycling,
and reduced long-term repopulating activity in HSCs. These
results demonstrated for the first time that TGF-b/Smad
signaling is active in BM HSCs and maintains their dormancy.
A Specialized Cell Type Produces Active TGF-b in BM
TGF-b is produced by a variety of cells, including HSCs, in
a latent form. However, HSCs cannot activate it by themselves
(Yamazaki et al., 2009). We thought that it may be critical to
identify cell types that can activate latent TGF-b in order to
understand the physiological role of TGF-b in BM. To address
this issue, we used two antibodies: anti-LAP antibody and anti-
TGF-b antibody. Both LAP and TGF-b exist as disulfide-linked
homodimers, and these molecules are noncovalently associ-
ated, forming the latent TGF-b complex. Anti-LAP antibody
was used to detect latent TGF-b. Anti-TGF-b antibody reacts
with TGF-b only after TGF-b is released from the latent TGF-b
complex. Anti-TGF-b antibody was used to detect active
TGF-b. Citric acid treatment can release TGF-b from the
latent TGF-b complex (Lyons et al., 1990). The specificity of
anti-TGF-b antibody was examined by ELISA. Anti-TGF-b anti-
body did not bind to TGF-b but bound to TGF-b after citric
acid treatment (Figure S2A). As reported previously (Yamazaki
et al., 2009), in vitro colony formation by CD34KSL HSCs is
inhibited by active TGF-b, but not by latent TGF-b. This colony
formation inhibited by active TGF-b was completely rescued
by addition of anti-TGF-b antibody, but not of anti-LAP antibody
(Figure S2B). These results indicate that the anti-LAP antibody
recognizes latent TGF-b in most cases and that anti-TGF-b anti-
body specifically recognizes active TGF-b.
Correspondingly, the two antibodies successfully unveiled
differential patterns of expression of latent TGF-b and activeell 147, 1146–1158, November 23, 2011 ª2011 Elsevier Inc. 1147
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Figure 1. Impaired HSC Function, Decreased Smad2/3 Phosphorylation, and Increased Cell Cycling in Tgfbr2-Deficient Mice
(A) Contribution of Tgfbr2+/Rag2/ or Tgfbr2del/Rag2/ cells to hematopoiesis detected 16 weeks after transplantation. Competitive repopulation assays
were performed using 13 106 BM cells from Tgfbr2+/Rag2/mice or Tgfbr2del/Rag2/mice (B6-Ly5.1) and the same number of BM competitor cells from F1
mice (B6-Ly5.1/5.2). Cells were transplanted into lethally irradiated B6-Ly5.2 mice. The repopulation capacity of test cells was monitored in terms of PB
chimerism of myeloid cells (n = 10).
(B) Time course analysis of chimerism. Chimerism for donor-derived cells was periodically analyzed in PB myeloid cells. Data are presented as mean ± SD
(n = 10).
(C) Phosphorylation status of Smad2 and Smad3 in wild-type BM as detected by immunostaining of frozen BM sections with DAPI (blue) and anti-p-Smad2/3
(green).
(D) Two-dimensional presentation of wild-type BM section data automatically assayed by ArrayScan. Frozen BM sections were stained with antibodies against
CD150 (red), against CD48, CD41, and lineage markers (green), and against pSmad2/3 (blue). Gated cells in a red square represent CD150+CD48CD41Lin
HSCs. Fluorescence photomicrographs show pSmad2/3 in CD150+CD48CD41Lin HSCs within the red square. A magnified image of smad2/3-positive
hematopoietic stem cells (arrowheads). See also Figure S1.
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TGF-b in BM sections fixed with dry ice-cold ethanol. LAP was
detected in various cells, including scattered megakaryocytes,
well known to produce latent TGF-b abundantly (Figure 2A),
whereas distribution of active TGF-b was highly restricted to
a minor population of LAP-positive cells that formed long, spin-
dled structures distinct from VE-cadherin-positive blood
vessels (Figures 2B and 2C). Of particular note, megakaryocytes
became reactive to anti-TGFb antibody only after citric acid
treatment (Figure S2C). These findings indicated that the fixa-
tion of BM sections with ethanol alone does not activate latent
TGF-b and further supported the specificity of anti-TGFb
antibody.
Latent forms of TGF-b accumulate in the ECM through direct
binding between the LTBP and ECM (Annes et al., 2003).
Although the precise mechanism of activation of latent TGF-b
is not clear, the integrins avb6 and avb8 most likely facilitate
proteolytic degradation of LAP by matrix metalloproteinases
(Annes et al., 2003, 2004; Munger et al., 1999; Mu et al., 2002).
In this regard integrin function is tightly linked with proteolytic
processes. LTBP was expressed in both long, spindled cells
and megakaryocytes (Figure S2D), indicating that these cells
produce abundant latent TGF-b. In contrast, integrin-b8 (Itgb8)
was specifically expressed by the long, spindled-cell structure
that marked abundantly for active TGF-b (Figure 2D), whereas
integrin-b6 expression was not detected in any BM stromal or
hematopoietic cells (data not shown).
BM Glial Cells Produce Active TGF-b
The aforementioned findings led us to identify BM cell types that
express Itgb8. RT-PCR analysis revealed that hematopoietic
cells and BM stromal cells did not express Itgb8 at all (Fig-
ure S3A). We then focused on GFAP-positive glial cells because
Schwann cells reportedly express Itgb8 (Figure S3A) (Cambier
et al., 2005; Chernousov and Carey, 2003). Schwann cells of
neural crest origin in the peripheral nervous system are the coun-
terparts of astrocytes in the central nervous system. There are
two types of Schwann cells: myelinating and nonmyelinating.
Myelinating Schwann cells, which provide the neural myelin
sheath, express myelin basic protein (MBP), but not GFAP. In
contrast, nonmyelinating Schwann cells, which ensheath several
small axons, express GFAP, but not MBP.Myelination occurs for
large axons 1–25 mm in diameter, whereas most postganglionic
autonomic axons are less than 1 mm in diameter and are unmy-
elinated (Jessen andMirsky, 2005). To learn if the cells of interest
were glial cells, we analyzed the expression inBMofGFAP, a glial
cell-specific member of the intermediate filament family (Cou-
lombe andWong, 2004). First, we characterized BMGFAP-posi-
tive cells in detail usingGFAP promoter-driven GFP (GFAP-GFP)
transgenic mice (Suzuki et al., 2003). The vast majority of GFP-
positive cells stained for active TGF-b (Figure 3A) and expressed
Itgb8 and S100b, amarker antigen for glial cells (Figures S3B and(E) Phosphorylation levels of Smad2/3 in Tgfbr2-deficient HSCs. CD34KSL HSC
after pIpC treatment, stained with anti-p-Smad2/3 antibody, and automatically
similarly stained with rabbit IgG control antibody. Data from two independent ex
(F) Cell cycle status of Tgfbr2-deficient HSCs. At 2 weeks after pIpC treatment, mi
mice for 7 days, CD34KSL HSCs were purified from Tgfbr2+/Rag2/ and Tgfbr
for BrdU uptake by ArrayScan (n = 5). Error bar represents SEM. **p < 0.001.
CS3C). These cells were much smaller in diameter than other
peripheral nerve cells, but the size and appearance of these
GFAP-positive cells were very similar to those described for
Schwann cells in the BM (Calvo and Forteza-Vila, 1970). To
confirm that these GFAP-positive cells were nonmyelinating
Schwann cells, we examined them using a confocal laser micro-
scope under high magnification. As shown in Figure 3B, GFAP-
positive cells were present in parallel with neurofilament
(NF)-positive axons. Analysis of transverse sections revealed
that GFAP-positive cells ensheathed NF- and tyrosine hydroxy-
lase (TH)-positive axons (Figures 3C–3E). Immunostaining of
transverse sections confirmed that these GFAP-positive cells
were positive for both active TGF-b and Itgb8 (Figures 3F and
3G). Additional costaining with anti-VE-cadherin and anti-
GFAP or anti-Itgb8 antibodies revealed that the VE-cadherin-
positive endothelial cells and GFAP- and Itgb8-positive cells of
interest were distinct and lay in parallel in close proximity (Fig-
ure S4;Movie S1). These results strongly suggested that the cells
that play a role in HSC hibernation were nonmyelinating
Schwann cells.
Mendez-Ferrer et al. recently reported that nestin-positive
MSCs are a component of the BM niche (Me´ndez-Ferrer et al.,
2010). Nestin is an intermediate filament expressed in various
cell types, including cells of the central and peripheral nervous
system and neural crest derivatives (Gue´rette et al., 2007). Using
an antibody against PDGFRa, a marker antigen for MSCs (Mor-
ikawa et al., 2009; Omatsu et al., 2010), we combined immuno-
histochemical and ArrayScan analyses to understand the rela-
tionship between GFAP-positive glial cells and MSCs.
PDGFRa-positive cells, nestin-positive cells, and GFAP-positive
cells represented 0.05%, 0.026%, and 0.004% of BM area,
respectively (Figure S5A). Of particular interest was that all
GFAP-positive cells were positive for nestin (Figures S5B and
S5C) but negative for PDGFRa (Figures S5B and S5D) and that
PDGFRa-positive MSCs were not positive for active TGF-b (Fig-
ure S5E). PDGFRa-positive MSCs and nestin-positive cells
largely overlapped but showed different distributions as well
(Figures S5B and S5F). These findings indicate that GFAP-posi-
tive cells and PDGFRa-positive MSCs were distinct. Expression
of smooth muscle actin, a marker of pericytes, was also lacking
in GFAP-positive cells (data not shown). Therefore, we
concluded that nonmyelinating Schwann cells distinct from
PDGFRa+ MSCs are the cells responsible for production of
active TGF-b.
A Significant Proportion of HSCs Exists in Contact
with Glial Cells
BM glial cells that produce Itgb8, which activates, TGF-b are
attractive candidates for BM niche cells. To determine whether
glial cells are in contact with HSCs in BM, we stained BM
sections with antibodies against CD150, CD48, CD41, ands were purified from Tgfbr2+/+Rag2/ and Tgfbr2del/Rag2/ BM at 2 weeks
assayed by ArrayScan. As a negative control, Tgfbr2+/+Rag2/ HSCs were
periments were pooled.
ce were given BrdU-containing water for 7 days. After administration of BrdU to
2del/Rag2/ BM cells, stained with an anti-BrdU antibody, and then analyzed
ell 147, 1146–1158, November 23, 2011 ª2011 Elsevier Inc. 1149
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Figure 2. A Specialized Cell Type Produces Active TGF-b in BM
(A) Distribution of latent TGF-b in BM. BM sections were stained with DAPI (blue) and anti-LAP antibody (green). Amagnified image of the boxed cell is depicted in
the inset.
(B) Distribution of active TGF-b in BM. BM sections were stainedwith DAPI (blue) and anti-TGF-b antibody (green). Amagnified image of the boxed cell is depicted
in the inset. Arrowheads indicate active TGF-b-positive endothelial cell-like spindle cells (arrowheads).
(C) Costaining of BM with anti-TGF-b and anti-VE-cadherin antibodies. BM sections were stained with DAPI (blue), anti-TGF-b antibody (red), and anti-VE-
cadherin antibody (green).
(D) Costaining of BM with anti-TGF-b and anti-Itgb8 antibodies. BM sections were stained with DAPI (blue), anti-TGF-b antibody (green), and anti-Itgb8 antibody
(red). All data were obtained by ArrayScan.
See also Figures S2 and S3.lineagemarkers to identify HSCs as well as simultaneously stain-
ing BM sections with antibodies against GFAP, osteocalcin,
and VE-cadherin. We then evaluated these sections quantita-
tively by ArrayScan to determine the positional relationships be-
tween HSCs and BM glial cells (Figure 4A). GFAP-express-
ing glial cells were in direct contact with 23.3% ± 5.4% of1150 Cell 147, 1146–1158, November 23, 2011 ª2011 Elsevier Inc.CD150+CD48CD41Lin HSCs (Figures 4B and 4C), whereas
13.3% ± 4.2% and 30.7% ± 3.7% of HSCs were in contact,
respectively, with osteocalcin-expressing osteoblastic cells
and VE-cadherin expressing vascular cells (Figures 4B, 4D,
and 4E). Although 32.7% ± 5.7% of HSCs lay apart from these
cells (Figure 4B), this may reflect our failure to detect HSC
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Figure 3. GFAP-Positive Cells Activate Latent TGF-b
(A) Expression of active TGF-b in GFAP-positive cells in BM. BM sections fromGFAP-promoter-driven GFP transgenic mice (GFAP-GFP) were stained with DAPI
(blue) and anti-TGF-b antibody (red), and immunofluorescence signals were overlaid with that of GFP. Representative magnified overlay images are presented.
(B) Longitudinal sections of GFAP-GFP transgenic mouse BM stained with anti-NF antibody (red). Representative magnified overlay images are presented.
(C–E) Cross sections of GFAP-GFP transgenic mouse BM. Unstained, low-magnification image (C) and cross sections of GFAP-GFP transgenic mouse BM
stained with anti-NF antibody (D) or with anti-TH antibody (red) (E) with higher magnification are shown.
(F and G) Cross sections of GFAP-GFP transgenic mouse BM stained with anti-TGF-b antibody or anti-Itgb8 antibody and with anti-NF antibody.
See also Figures S3, S4, and S5, and Movie S1.contact in 2-dimensional BM section scans. Alternatively, HSCs
may have been in contact with as yet unidentified cells. Of partic-
ular interest is that CD34+KSL progenitor cells lay apart from
glial cells (data not shown). Furthermore, GFAP-expressing glial
cells were not detected in fetal livers, in which developing
HSCs are in the cell cycle as their numbers expand (Morrison
et al., 1995).CGlial cells have never been examined for a niche cell-like
capacity to support HSCs. Although BM cells enriched in
Schwann cells could not be prepared, Schwann cells prepared
from sciatic nerves expressed Tgfb1, Tgfb2, and Tgfb3 as well
as Itgb8. Surprisingly, they also expressed major HSC niche
factor genes, including Cxcl12, c-kit ligand (kitl), anginpoitin-1
(Angpt1), and Tpo (Figure S6).ell 147, 1146–1158, November 23, 2011 ª2011 Elsevier Inc. 1151
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Figure 4. HSCs Exist in Contact with Glial Cells
in BM
(A) Two-dimensional presentation of wild-type BM section
data automatically acquired by ArrayScan. Frozen BM
sections were stained with antibodies against CD150
(red), CD48, CD41, and lineage markers (green), and
GFAP (blue). Gated cells in a red square represent
CD150+CD48CD41Lin HSCs.
(B) Positional relationship of HSCs with niche cells. Data
from whole BM sections imaged by ArrayScan were
analyzed in terms of the positional relationship of HSCs
with niche cells, including osteocalcin-positive osteo-
blastic niche cells and VE-cadherin-positive vascular
niche cells together with GFAP-positive glial cells. Frozen
wild-type BM sections were stained with anti-CD150 (red),
anti-CD48, -CD41, and -lineage markers (green), and anti-
GFAP (blue) antibodies. ArrayScan data from whole BM
sections were analyzed for positional relationships
between HSCs and known niche cells (n = 10). Error bar
represents SD.
(C) Representative fluorescence micrographs of colocal-
izing HSCs (boxed in A) with GFAP-positive glial cells.
Frozen wild-type BM sections were stained with anti-
bodies against CD150 (red), against CD48, CD41, and
lineage markers (green), and against GFAP (blue). Magni-
fied images are shown in the insets.
(D and E) Representative fluorescence images of HSCs
colocalizing with VE-cadherin-positive vascular niche cells
(D) and osteocalcin-positive osteoblastic niche cells (E)
(boxed). Frozen wild-type BM sections were stained with
antibodies against CD150 (red), against CD48, CD41, and
lineage markers (green), and against VE-cadherin or
osteocalcin (blue).
See also Figures S1 and S6.Denervation of Sympathetic Nerve Results in Loss
of HSCs
To provide direct evidence that BM Schwann cells are a compo-
nent of the BM niche and were responsible for the maintenance
of HSCs’ hibernation state, we attempted to delete ensheathing
glial cells in BM via Wallerian degeneration by transecting post-
ganglionic sympathetic nerves directly (Fernando et al., 2002).
Although denervation of sciatic myelinated motor axons was
reported to induce proliferation of myelinating Schwann cells
(Murinson and Griffin, 2004), other studies indicated that
Schwann cells undergo prompt apoptotic cell death in the nerve
distal to axotomy both in neonates (Grinspan et al., 1996) and in
adult rodents (Sulaiman et al., 2002). Nerve injury reduces neure-
gulin-1 signaling and leads to apoptosis of Schwann cells (D’An-
tonio et al., 2006). Based on the assumption that similar loss of
nonmyelinating Schwann cells by apoptosis would occur, the1152 Cell 147, 1146–1158, November 23, 2011 ª2011 Elsevier Inc.lumbar sympathetic trunk was cut unilaterally
at the level of L2, L3, and L4 to denervate
sympathetic nerves to the biceps femoris
muscle and the BM, with a sham operation per-
formed contralaterally. This surgical procedure
spared motor and sensory nerves, leaving the
animal’s motion intact (Noguchi et al., 1999),
and resulted in significant decreases in the
number of GFAP-positive cells as well as ofactive TGF-b-positive cells (Figure 5A). Loss of GFAP-positive
cells was also confirmed by S100b staining (data not shown).
Although total BM cells did not differ significantly in number
between left and right femora (data not shown), loss of HSCs
on the denervated side was manifested as early as day 3 after
surgery, and HSC numbers fell to one-fifth of those in contralat-
eral BM by day 7 (Figures 5B and 5C). Although we cannot
exclude the possibility that sympathetic denervation induces
secondary injury, we confirmed that the integrity of other BM
niche components such as VE-cadherin-positive endothelial
cells, PDGFRa-positive MSCs, and osteocalcin-positive osteo-
blasts remained intact at 1 week after denervation (Figure 5D).
To confirm the loss of HSCs after denervation, we performed
competitive repopulation analyses using BM cells harvested
1 month after sympathetic nerve transfection. One million cells
from denervated or contralateral BM were transplanted into
AB C
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Figure 5. Denervation of Sympathetic Nerve Results in Loss of HSCs
(A) Distribution of GFAP-positive and active TGF-b-positive cells in BM after sympathetic nerve denervation. BM sections were stained with DAPI (blue) and with
anti-GFAP antibody (red, left panels) or anti-TGF-b antibody (data not shown). Control sections were obtained from contralateral sham-operated BM. Right
panels demonstrate results of quantitative analysis of fluorescence-positive area for GFAP or TGF-b in BM section by ArrayScan software (n = 10). Error bar
represents SEM. *p < 0.01.
(B) Frequencies of c-Kit+Sca-1+ cells in CD34Lin cells in control and denervated BM.
(C) Time course analysis of frequencies of CD34KSL HSCs in control and denervated BM. Frequencies of CD34KSL/BM cells are depicted. Data are presented
as mean ± SD (n = 4).
(D)DistributionofVE-cadherin-,PDGFRa-, andosteocalcin-positivenichecells inBMafter autonomicnervedenervation.BMsectionswerestainedwithDAPI (blue)
and with anti-VE-cadherin antibody, anti-PDGFRa antibody, or anti-osteocalcin antibody (green). Control sections were obtained from contralateral, sham-
operatedBM.Lowerpanelsdemonstrate results of quantitative analysis of fluorescence-positive areas forVE-cadherin, PDGFRa, or osteocalcin inBMsections, as
determinedbyArrayScansoftware (n=10). Errorbar representsSEM.Nostatistically significantdifferencebetweencontrol anddenervatedBMwasdemonstrated.
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Figure 6. Sympathetic Nerve Denervation Com-
promises Dormancy of HSCs
(A) Results of long-term competitive repopulation analysis.
One million BM cells 1 month after denervation were
transplanted into lethally irradiated mice together with 13
106 total BM competitor cells. Four months later, donor
chimerism in PB was determined by FACS. Sham-oper-
ated contralateral BM cells were used as controls. Data
are presented as mean ± SD (n = 10). **p < 0. 001.
(B) Capacity of purified CD34KSL HSCs for long-
term repopulation and hematopoiesis. Forty purified
CD34KSL HSCs 1 month after denervation were trans-
planted into lethally irradiated mice together with 1 3 106
total BM competitor cells. Four months later, donor
chimerism in PB was determined by FACS. CD34KSL
HSCs from sham-operated contralateral BM cells were
used as controls. Data are presented asmean ± SD (n = 5).
(C) Frequencies of CD34KSL/BM cells in control and BM-
denervated mouse BM and spleen 1 week after denerva-
tion. Data are presented as mean ± SD (n = 5).
(D) Phosphorylation levels of Smad2/3 in HSCs after
selective denervation. CD34KSL HSCs were purified
from control and denervated BM at day 7 after denerva-
tion, stained with anti-p-Smad2/3 antibody, and assayed
by ArrayScan. **p < 0. 001.
(E) Cell cycle status of HSCs in denervated BM. One week
after denervation, mice were fed with BrdU-containing
water for 7 days, thenCD34KSLHSCswere isolated from
control or denervated BM, stained with anti-BrdU anti-
body, and analyzed by ArrayScan. Data are presented as
mean ± SD (n = 3). **p < 0. 001.
(F) Restoration of HSC dormancy by infusion of active
TGF-b. One week after denervation, administration of
either latent or active TGF-b (lTGF and aTGF, respectively)
began, infused intraperitoneally into mice every other day
at a dose of 40 mg/kg. BrdU in drinking water also was
begun. Intraperitoneal infusions and BrdU administration both were given for 1 week. At day 14 after denervation, CD34KSL HSCs were isolated, stained with
anti-BrdU antibody, and analyzed by ArrayScan. Data are presented as mean ± SD (n = 3). **p < 0. 001.lethally irradiated CD45-congenic mice together with 1 3 106
competitor BM cells (also from CD45 congenic mice). Three
months later, donor chimerism in PB was analyzed. The results
showed significantly lower chimerism achieved using BM cells
derived from the denervated side than that derived from the
sham-operated contralateral side (denervated BM cells, 12.4% ±
2.4%: control BM cells, 53.5% ± 6.2%) (Figure 6A), supporting
our observation that the frequency of HSCs was reduced by the
effects of denervation. We also performed competitive repopula-
tion assays using CD34KSL cells purified from denervated BM
in comparison with those from control BM and observed no
significant difference between them (Figure 6B). These results
support the interpretation that the quantity but not the quality
of HSCs is responsible for decreased reconstitution activity in
denervated BM. To examine the possibility that HSC numbers
were reduced in BM because of their mobilization, we examined
PB and spleen for the presence of CD34KSL HSCs before and
after denervation but did not observe any increase of HSCs
either in PB or in spleen (Figure 6C; data not shown).
Notably, aswas the casewith Tgfbr2del/Rag2/HSCs in Fig-
ure 1E, the levels of pSmad2/3 were significantly downregulated
in HSCs after selective denervation (Figure 6D). To examine cell
cycle status, we then isolated HSCs from denervated femora of
mice that had been given BrdU for 7 days. The HSCs were1154 Cell 147, 1146–1158, November 23, 2011 ª2011 Elsevier Inc.stained with FITC-conjugated anti-BrdU antibody and analyzed
by ArrayScan. Significantly higher proportions of HSCs isolated
from denervated BM were positive for BrdU than of those from
control BM (Figure 6E). These data strongly indicate that the glial
cell component of the niche is responsible for themaintenance of
HSC hibernation in BM by regulating the process by which latent
TGF-b is activated.
This concept was supported by the effects of exogenous
latent and active TGF-b on HSCs in denervated mice. Beginning
1 week after denervation, either latent or active TGF-b was
infused into mice every other day for 1 week, and BrdU-contain-
ing water was given throughout the same week. Cell cycle anal-
ysis at day 14 after denervation revealed that active TGF-b signif-
icantly suppressed active cycling of HSCs in denervated mice,
whereas latent TGF-b did not (Figure 6F). These results confirm
the cytostatic effect of active TGF-b on HSCs and underline
the role of the glial cell component of the niche in converting
latent TGF-b into active TGF-b.
DISCUSSION
We have shown in this study that Smad2 and Smad3 are acti-
vated in HSCs in BM. Tgfbr2del/ HSCs showed profoundly low
levels of Smad2 and Smad3 phosphorylation and were defective
with respect to the long-term repopulating capacity of hemato-
poiesis. As previously reported (Yamazaki et al., 2006, 2009),
TGF-b may tune down cytokine signals by inhibiting cytokine-
induced lipid raft clustering. By doing so, TGF-b keeps the
PI3K-Akt pathway suppressed and induces cyclins D1, D2,
and D3 distancing from the nucleus, whereas it stabilizes
FoxO1, 3a, and 4, permitting them to function in the nucleus.
TGF-b also activates Smad2 and Smad3 and supposedly regu-
lates transcription of p57Kip2 for example, the cyclin-dependent
kinase inhibitor gene highly expressed in dormant HSCs (Yama-
zaki et al., 2006). Regulation of these machineries is reportedly
critical to maintenance of the dormant state in HSCs (Oguro
and Iwama, 2007; Yilmaz et al., 2006; Zhang et al., 2006; Kozar
et al., 2004; Tothova et al., 2007; Miyamoto et al., 2007; Yoshi-
hara et al., 2007). Although the defects in Tgfbr2del/ HSCs
were relatively mild compared with those in mice deficient in
Smad4 (Karlsson et al., 2007), which acts at a common level of
convergence for all TGF-b superfamily signals, all these in vivo
findings define the TGF-b/Smad signal as one of the critical niche
signals in the maintenance of HSCs. Correspondingly, a critical
role of TGF-b has recently been reported in the maintenance of
quiescence and immaturity of melanocyte stem cells (Nishimura
et al., 2010). Therefore, the TGF-b signal could have a general
impact on the maintenance of stem cell dormancy.
Latent TGF-b, produced by a variety of BM cells, is broadly
distributed within BM. However, active TGF-b is exclusively
detectable in nonmyelinating Schwann cells that lay in parallel
with blood vessels. These glial cells in BM express not only
stem cell niche genes, but also Itgb8. Upon cell-to-cell contact,
integrin-avb8 of Schwann cells supposedly binds to LAP and
changes the conformation of the latent TGF-b complex. The
consequent exposure of the cleavage site for proteolytic degra-
dation by plasmin and metalloproteinases results in production
of active TGF-b. Thus, in BM, function of TGF-b appears tightly
regulated by an activation process. Active TGF-b triggers the
Smad signaling pathway, causing hibernation in HSCs. Given
that TGF-bs are prone to degradation, they may act locally at
the glial niche without diffusing to distant progenitor cells. That
TGF-b should regulate HSCs locally is reasonable if the highly
cytostatic activity of TGF-b is to be restricted to dormant HSCs.
Smad2 and Smad3 were activated in most HSCs, whereas
only 25% of HSCs were in contact with the glial component of
the niche. This finding raises the possibility that HSCs, depend-
ing on their activation status, shift among various compartments
of the niche. Once Smad2 and Smad3 are activated via the glial
component of the niche, HSCs may retain Smads in active form,
even after relocation into another compartment, until the HSCs
receive cues for cell division. Alternatively, by shifting away
from glial cells, Smad signaling is downregulated, and therefore,
HSCs may regain the ability to form lipid raft clusters and to be
aroused from hibernation to enter the cell cycle. Another possi-
bility is that usage of signaling molecules by different TGF-b
superfamily ligands overlaps. Absence of TbRI reportedly does
not affect the hematopoietic system (Larsson and Karlsson,
2005). Here, we demonstrated HSC abnormalities in Tgfbr2-defi-
cient mice. These observations are in accordance with the fact
that Tgfbr2 is expressed in HSCs, but Tgfbr1 is not (Utsugisawa
et al., 2006; Yamazaki et al., 2009). This adds to the complexCroles of ligands, receptors, and Smads in TGF-b signaling in
HSCs (Karlsson et al., 2007). A recent study has demonstrated
that mice deficient in both Smad1 and Smad5 have no hemato-
poietic abnormalities (Singbrant et al., 2010). On the other hand,
mice deficient in Smad4 show HSC abnormalities similar to
those in Tgfbr2-deficient mice (Karlsson et al., 2007). These
data suggest that signaling downstream from TbRII but not
from bone morphogenetic protein receptors plays a role in the
maintenance of HSCs in BM. However, how TGF-b conveys
signals into the cell without TbRI remains to be elucidated.
TbRI is a member of the ALK family. As far as we and others
have been able to determine (Utsugisawa et al., 2006), expres-
sion of othermembers of the ALK family in HSCs is barely detect-
able. To understand the whole picture of regulation of HSC
dormancy by TGF-b superfamily, further characterization is
required.
To observe the contribution of the nervous system to hemato-
poiesis, we performed ischiac nerve denervation (data not
shown) as well as selective sympathetic denervation. Surpris-
ingly, in both cases, denervation resulted in significant
decreases in the number of BM glial cells and of cells expressing
active TGF-b. In parallel we observed a drastic reduction in HSC
numbers, with the HSCs present found to be actively cycling.
This finding supports the idea that neural regulation plays
a role in homeostasis of hematopoiesis. Other studies have
also shown that signals from the sympathetic nervous system
enhance HSC egression from the BM osteoblastic niche through
suppression of Cxcl12 production (Katayama et al., 2006). Circa-
dian noradrenalin secretion by the sympathetic nervous system
also regulates Cxcl12 expression in the BM microenvironment,
thereby regulating release of HSCs from their niche (Me´ndez-
Ferrer et al., 2008). Moreover, catecholaminergic pathways can
promote human CD34+ cell migration and engraftment by acting
directly on HSC/progenitor cells (Spiegel et al., 2007). This
sympathetic nerve regulation of HSC maintenance reportedly
is mediated indirectly by Nestin+ MSCs expressing b3-adren-
ergic receptor (Me´ndez-Ferrer et al., 2010). However, the
present work implicates BM glial cells of the autonomic nervous
system in direct regulation of HSCs. By regulating the activation
process of TGF-b, these glial cells appear to control hibernation
of HSCs in BM. How these two components of the BM niche are
related in the maintenance of homeostasis of HSCs under the
influence of the autonomic nervous system remains an intriguing
issue. Identification of glial cells as BM HSC niche components
opens up a new area of research that links the neural and hema-
topoietic systems.EXPERIMENTAL PROCEDURES
Mice
C57BL/6 (B6-Ly5.2) mice were purchased from SLC (Shizuoka, Japan).
C57BL/6mice congenic for the Ly5 locus (B6-Ly5.1) were bred andmaintained
at Sankyo Lab Service (Tsukuba, Japan). C57BL/6-Ly5.1/Ly5.2 F1 mice were
used for competitive reconstitution assays. Tgfbr2+/Rag2/ mice were ob-
tained by mating Tgfbr2+/ mice (Oshima et al., 1996) with Rag2/ mice. To
generate Mx-1-Cre; Tgfbr2flox/Rag2/ mice, Tgfbr2flox/+ mice (Leve´en
et al., 2005) were crossed with interferon-inducible Mx-1-Cre transgenic
mice and Rag2/mice. To induceCre, mice received 250 mg of pIpC intraper-
itoneally three times every other day. GFAP-promoter GFP mice have beenell 147, 1146–1158, November 23, 2011 ª2011 Elsevier Inc. 1155
described (Suzuki et al., 2003). Mice were bred and maintained at the Animal
Research Facility of the Institute of Medical Science, University of Tokyo.
Animal care was carried out in accordance with the guidance of the University
of Tokyo for animal and recombinant DNA experiments.
Analysis and Purification of Mouse HSCs and CD34+KSL Cells
Mouse CD34KSL HSCs and CD34+KSL MPPs were purified from BM of
2-month-old mice. The cells were stained with an antibody cocktail consisting
of biotinylated anti-Gr-1, -Mac-1, -B220, -CD4, -CD8, and -Ter-119 mono-
clonal antibodies (lineage-marker cocktail) (PharMingen, San Diego, CA,
USA). Lineage-positive cells were depleted with anti-rat MicroBeads (Miltenyi
Biotec, BergischGladbach,Germany). The remaining cellswere further stained
with fluorescein isothiocyanate (FITC)-conjugated anti-CD34, phycoerythrin
(PE)-conjugated anti-Sca-1, and allophycocyanin (APC)-conjugated anti-
c-Kit antibodies (PharMingen). Biotinylated antibodies were detected with
streptavidin-APC-Cy7 (PharMingen). Analysis and cell sorting were performed
on a MoFlo using Summit software (Beckman Coulter, Fullerton, CA, USA),
and results were analyzedwith FlowJo software (Tree Star, Ashland, OR, USA).
Immunofluorescence Staining of BM Sections
Frozen BM sections were prepared and immunostained according to the Ka-
wamoto method (Kawamoto, 2003). BM sections were fixed using dry ice/
ethanol or 4% paraformaldehyde (PFA). Immunofluorescence data were ob-
tained and analyzed with a TCS SP2 AOBS confocal microscope (Leica,
Microsystems, Tokyo) or a Cellomics ArrayScan VTI HCS Reader (Thermo
Scientific, Pittsburgh), a modular high-content screening instrument designed
for high-capacity automated fluorescence cell imaging with quantitative anal-
ysis. The immunofluorescence-microscopy images of BM sections were auto-
matically obtained, using integrated reader software, from multiple replicates.
Markers and antibodies used were: 4,6-diamidino-2-phenylindole (DAPI),
a DNA marker; Alexa 405-conjugated goat anti-rabbit IgG, Alexa 488-conju-
gated goat anti-chicken IgG, and Alexa 647-conjugated goat anti-rabbit IgG
(Molecular Probes, Carlsbad, CA, USA); rabbit anti-GFAP (Dako, Glostrup,
Denmark); goat anti-LAP (latent TGF-b) and rabbit anti-TGF-b (R&D systems,
Minneapolis); rabbit anti-osteocalcin (Lifespan, Seattle); rabbit anti-Itgb8 and
anti-LTPB1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA); rabbit anti-
phospho-Smad2/3 (Chemicon, Temecula, CA, USA); chicken anti-neurofila-
ment (Millipore, Billerica, MA, USA); chicken anti-nestin and rabbit anti-
S100b (Abcam, Cambridge); rabbit anti-tyrosine hydroxylase (Cell signaling,
Charlottesville, VA, USA); and Alexa 488-conjugated rat anti-VE-cadherin,
FITC-conjugated rat anti-CD41, FITC-conjugated anti-CD48, FITC-conju-
gated lineage-marker cocktail, PE-conjugated rat anti-CD150, APC-conju-
gated rat anti-CD150, and APC-conjugated rat anti-PDGFRa (BioLegend,
San Diego, CA, USA).
Immunofluorescence Staining of HSCs
CD34KSL cells were sorted into a droplet of serum-free culture medium
made on glass slides. The sorted cells were incubated at 37C for the indicated
time periods. After fixation with 2% PFA and blocking in 10% goat serum for
1 hr at room temperature, cells were incubated with a primary antibody for
12 hr at 4C. The cells were then washed and were incubated with a secondary
antibody for 30 min at room temperature. Immunofluorescence data were
obtained and analyzed with a Cellomics ArrayScan VTI HCS Reader (Thermo
Scientific).
Preparation of Primary Schwann Cells
GFAP-positive primary glial cells were prepared from the sciatic nerve of adult
C57BL/6 GFAP-GFP mice using forceps under the stereoscopic microscope
(Leica, Microsystems, Tokyo).
Competitive Repopulation Assays
Competitive repopulation assays were performed using the Ly5 congenic
mouse system. A total of 1 3 106 BM cells from Tgfbr2del/Rag2/ mice
(B6-Ly5.1) and the same number of BM competitor cells from B6-F1 mice
of Ly5.1 and 5.2 mice were transplanted into B6-Ly5.2 mice irradiated
at a dose of 9.5 Gy. For denervated mice, 1 3 106 BM cells or 40 HSCs
(B6-Ly5.1) obtained 1 month after denervation and 1 3 106 BM competitor1156 Cell 147, 1146–1158, November 23, 2011 ª2011 Elsevier Inc.cells from B6-F1 mice of Ly5.1 and 5.2 mice were transplanted into B6-
Ly5.2 mice irradiated at a dose of 9.5 Gy. After transplantation, PB cells of
the recipients were stained with biotinylated anti-Ly5.1 and FITC-conjugated
anti-Ly5.2. The cells were further stained with APC-conjugated anti-Mac-1
and -Gr-1 antibodies and with PE-conjugated streptavidin (PharMingen).
The cells were analyzed on a FACS Aria (Becton Dickinson, Franklin Lakes,
NJ, USA). Percent chimerism was calculated as (percent Ly5.1 cells) 3 100/
(percent Ly5.1 cells + percent F1 cells).
RT-PCR
Semiquantitative RT-PCR was carried out using cDNA normalized by quanti-
tative PCR with TaqMan rodent GAPDH control reagent (Perkin-Elmer Applied
Biosystems, Foster City, CA, USA). The primer sequences were: Itgb8 sense
50-CCTGCAGTGAAAACTGGA-30, antisense 50-TTT CTC ACG TCG GTA
GGT-30; Cxcl12 sense 50-GCA TCA GTG ACG GTA AAC CAG-30, antisense
50-GGG TCA ATG CAC ACT TGT CTG-30; kitl sense 50-GAA TCT CCG AAG
AGG CCA GAA ACT AGA TCC TTT-30, antisense 50-CGT CCA CAA TTA
CAC CTC TTG AAA TTC TCT CTC-30; Angpt1 sense 50-CAT TCT TCG CTG
CCA TTC TG-30; antisense 50-GCA CAT TGC CCA TGT TGA ATC-30; and
Tpo sense 50-CCT CTT CTT GAG CTT GCA AC-30; antisense 50-AGC CAT
GAG TTC CAT TCA C-30. Cycling parameters were: denaturation at 95C for
15 s, annealing at 58C for 15 s, and extension at 72C for 30 s. Amplification
proceeded for 38 or 40 cycles. PCR products were separated on agarose gels
and were visualized by ethidium bromide staining.
Denervation of BM
The lumbar sympathetic trunk was cut unilaterally at the level of L2, L3, and L4
to denervate sympathetic nerves to the biceps femoris muscle and the BM.
After the wounds were sutured, the animals were returned to their cages for
3–30 days before sacrifice and study. This surgical procedure spares motor
and sensory nerves, leaving the animal’s motion intact (Noguchi et al., 1999).
Cell Cycle Analysis
To investigate the turnover rate of CD34KSL cells, BrdU (Sigma-Aldrich) was
administered continuously tomice via drinking water (0.5mg/ml). After 1 week,
CD34KSL cells were isolated and stained with FITC-conjugated anti-BrdU
antibody (Molecular Probes). The cells then were analyzed by ArrayScan.
Administration of TGF-b to Denervated Mice
Beginning on the seventh day after denervation, either latent TGF-b (recombi-
nant human LAP [TGF-b1]; R&D Systems) or active TGF-b (recombinant
human TGF-b1; R&D Systems) was infused intraperitoneally into mice every
other day at a dose of 40 mg/kg.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and one movie and can be
found with this article online at doi:10.1016/j.cell.2011.09.053.
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